Baird Financial Group, Inc.

Position in INVA — Innoviva, Inc.

CIK 1648711 MILWAUKEE, WI

Position in INVA

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$6,231,419

+$5,810,322 QoQ

Shares Held

274,391

+763.4% QoQ

Ownership

0.380%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#44

of 306 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Baird Financial Group, Inc. holds $221,188,371 across 29 Biotechnology names. INVA ranks #5 (2.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ONC	BeOne Medicines Ltd.	368,978	$105,147,660
2	REGN	Regeneron Pharmaceuticals, Inc.	52,845	$32,950,970
3	INCY	Incyte Corp	224,855	$25,489,561
4	EXEL	Exelixis, Inc.	437,138	$23,784,676
5	INVA	Innoviva, Inc. This page	274,391	$6,231,419
6	BBIO	BridgeBio Pharma, Inc.	38,672	$2,880,290
7	ASND	Ascendis Pharma A/S	10,735	$2,863,239
8	LGND	Ligand Pharmaceuticals Inc	8,550	$2,702,569

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,231,419	274,391	+763.4%	Shares	Defined	2026-08-12
2022-12-31	$421,097	31,781	+6.1%	Shares	Defined	2023-02-13
2022-09-30	$347,870	29,963	-18.9%	Shares	Defined	2022-11-15
2022-06-30	$545,293	36,944	-29.0%	Shares	Defined	2022-08-08
2022-03-31	$1,006,316	52,006	+14.4%	Shares	Defined	2022-05-13
2021-12-31	$784,391	45,472	+17.8%	Shares	Defined	2022-02-09
2021-09-30	$645,088	38,605	+75.0%	Shares	Defined	2021-11-12
2021-06-30	$295,891	22,065	-17.6%	Shares	Defined	2021-08-11
2021-03-31	$320,044	26,782	+60.7%	Shares	Defined	2021-05-13
2020-12-31	$206,466	16,664	+11.1%	Shares	Defined	2021-02-11
2020-09-30	$156,791	15,004	+4.4%	Shares	Defined	2020-11-12
2020-06-30	$201,004	14,378	-29.7%	Shares	Defined	2020-10-22
2020-03-31	$240,409	20,443	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.